Editorial Board
Igor Grachev, M.D., Ph.D.
Professor
New Growth Franchise Head, Clinical, Medical and Drug Safety, Novartis Consumer Health, NJ, USA
Research Interest: 1) Neurobiology of Neurodegenerative disorders (Parkinsons disease, Alzheimers disease, Multiple Sclerosis) 2) OCD, Depression, Anxiety, Schizophrenia, ADHD, Chronic Pain, Stroke and other indications 3) Expert in clinical biomarkers and the following Imaging modalities: PET, SPECT, and MRI (Gd-MRI, vMRI, fMRI, MRS, DCE-MRI).
Editorial Board Members
Huang Wei Ling, MD
Homero Pacheco Alves, 1929 - FRANCA - SÃO PAULO - Brazil - 14.400-010
Jude Savarraj, MSc, PhD
The University of Texas Medical School at Houston,USA
John Patrick F Bebawy, M.D. Ph.D
Associate Director Of Neurosurgical Anesthesiology, Northwestern Memorial Hospital,Chicago, Illinois, USA
Geetanjali Rathore, MD
Director Neuromuscular Clinic Childrens Hospital and Medical Center Omaha, NE, USA
Jatin Machhi, Ph.D
Pharmacology & Experimental Neuroscience USA
Khue vu nguyen, p.hd
Departments of Medicine and Pediatrics, University of California, San Diego, School of Medicine, San Diego, California, U.S.A.
Brandon Lucke-Wold, p.hd
Department of Neurosurgery, University of Florida, USA.
ALAIN L FYMAT, PhD
Professor, International Institute of Medicine and Science, CA 92270, USA
LUISA GUADALUPE LIRA JUAREZ, Medical Doctor
Augusto Rodin Street 395, San Juan Benito Juárez, Mexico City,USA
Bahaa Kenawy Abuel-Hussien Abdel-Salam, Ph.D
Zoology Department, Faculty of Science, 61519, Minia University,El-Minia, Egypt
GIUSEPPE LANZA, MD PHD
VIA SANTA SOFIA 78, 95123, CATANIA, ITALY